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INTRODUCTION
Untreated chronic pain is a devastating symptom in older people with moderate to severe dementia who are unable to explain their suffering. 1 Persistent pain results in a progressive decline of functional and mental capacity, 2 social interaction 3 and quality of life, [4] [5] [6] appetite 7, 8 and sleep disturbances, 9, 10 and increased behavioural disturbances including agitation, depression and anxiety. [11] [12] [13] Pain causes immense stress for the patient, their formal and informal care givers 14, 15 and increases health care costs. 16, 17 In the last decades, clinicians and scientists concentrated on the prevalence, 18 assessment 19, 20 and treatment of pain in older people with mental impairment and the consequences of undetected and untreated pain. [21] [22] [23] [24] [25] Such issues include the development of observational and behavioural pain assessment instruments, pain treatment recommendations, and staff educational programs. Although these are necessary and central investments, the most pressing matter for mentally impaired individuals is the analgesic treatment of pain.
Compared to community-dwelling older adults who experience daily pain in 35% to 48% of the cases, 26 nursing home patients with dementia are described to be in daily pain in around 45% to 80% of the cases. 18 Numerous prevalence studies give a description of the under-treatment of pain in these settings. There are several explanations for insufficient management of pain in patients with mental impairment.
Today, the evidence base is still limited with regard to the balancing act between under-and over-treatment of pain in dementia and guides for treatment decisions. The type and dosage of analgesics are still based on clinical judgment of older adults without dementia. Although efficacy studies of analgesics in nursing home patients with dementia are challenging, these trials are possible and tremendously necessary.
In this review, we present a summary of the evidence for the assessment of pain in patients with dementia, the frequency of pain in these individuals, and benefit and harm related to the use of analgesics. We will also briefly present current pain assessment tools and treatment recommendations.
With respect to the source of the treatment group, older adults, the American Geriatric Society (AGS) Panel on Persistent Pain in Older Persons defined persistent pain as "an unpleasant, sensory and emotional
This review is informed by a unsystematic search of the PubMed (N=186), EMBASE (N=143) and Cochrane (N=11) databases conducted in collaboration with the library of the University of Bergen, Norway.
Search terms: "dementia", "Alzheimer disease", "pain management", "analgesics", "anti-inflammatory agents, nonsteroidal", "acetaminophen", "paracetamol", analgesics, opioid", "opioid", "morphine", buprenorphine", "oxycodone". Sensitive for EMBASE, we used the filter for therapy: Random OR clinical trial OR exp. health care quality.
Box 2.
European COST-Action TD 1005.
Authors of this article represent European COST-Action TD 1005 (Pain Assessment in Patients with Impaired Cognition, especially in Dementia), Work Group 1 (Psychometrics and Algesimetry). COST-Action TD 1005 consists of basic and clinical scientists in pharmacy, dementia, pain, nursing and palliative care with members from Belgium, Cyprus, Denmark, France, Germany, Israel, Italy, Norway, Romania, Spain, Switzerland, The Netherlands, United Kingdom, and Australia. http://www.cost-td1005.net/home.html. It is the task of this work group to investigate whether the existing pain behavioural instruments are appropriate to use for people with moderate and severe dementia. We will particularly consider whether pain behaviours related to facial expression, vocalization and body movements are assessed in line with recommendations for pain assessment in dementia by the American Geriatric Society. The results of psychometric testing will also be considered. Outputs will be delivered to the other working groups (WG 2-5) for a second opinion and further work in the development of a comprehensive toolkit for pain assessment in cognitively impaired patients.
experience that continues for a prolonged period of time that may or may not be associated with a recognizable disease process". 21 The definition is based on the declaration by the International Association for the Study of Pain (IASP), who underlines that the most exact and trustworthy verification of the assessment of pain is the patient's self-report, depending on the patient's memory, verbal capacity, expectations and emotions. 27 Because of their inherent subjectivity, pain and suffering are difficult to objectively verify, disprove, or quantify. Given that pain self-report is often no longer available in patients with moderate to severe dementia, the AGS Panel underlined the wide variability and complexity of pain diagnosis, physical disabilities and analgesic use in these individuals. 21, 22, 28 A comprehensive, disease-specific, individual assessment of the patients' typical pain behaviour are recommended, using a validated pain assessment tool as a prerequisite for appropriate pain treatment. Following this, an increasing number of population-based and cross-sectional studies suggest that pain-related problems are highly present in community-dwelling elderly people and those living in care homes, with and without dementia.
PAIN PREVALENCE IN OLDER ADULTS
Chronic musculoskeletal pain affects over 100 million people in Europe and is by far the most common limiting factor on activities of the ageing population. Musculoskeletal pain increases the risk of reduced mobility, disability and muscle weakness, and reduces the health-related quality of life. 26 In older people, chronic pain is often experienced in major joints, the back, legs and feet, and it is reported more often than visceral pain and headaches. 29 Chronic pain is mostly nociceptive, around 10% is neuropathic, and 1 of 3 patients is believed to suffer from a combination of neuropathic and nociceptive pain.
In a cross-sectional survey of an older rural community in Italy, about one third of the population was affected by symptomatic peripheral osteoarthritis in knees, hands, and hips, which were strongly associated with disabilities. 30 About 71% of the veterans in a primary care clinic in New York described pain with multiple localizations, also in coexistence with psychological and social problems. 31 Other studies have shown that musculoskeletal pain caused by osteoarthritis is associated with decreased balance, week knee strength 32 and risk of falls.
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PAIN PREVALENCE IN NURSING HOME
PATIENTS
Between 45% to 83% of the patients living in nursing homes experience acute or chronic pain, particularly those with moderate to severe dementia. Most of them (about 94%) suffer from persistent pain (3-6 months or more), 34 often located in the musculoskeletal system. 35 But pain problems are not only movement related. About 40% experience pain in internal organs, head and skin, which is more challenging to quantify. 36 Elderly patients with visceral painful conditions are far more likely than younger adults to present atypical pain, and often with diminished intensity. 29 Silent ischemia and painless myocardial infarct caused by arteriosclerosis become more frequent with advancing age. 37, 38 Peptic ulcers, intestinal obstruction, and peritonitis are other visceral conditions, often with reduced or absent abdominal complaints, 29 and about 45% of older persons with appendicitis do not have typical lower-right quadrant pain as a presenting symptom, compared with 5% of younger adults. 39 Living in a nursing home, 53% of the patients are at risk of developing a pressure ulcer, 40 and skin diseases found in 95% of the patients were described as one of the most prevalent health problems. 41 Pain in connection with genito-urinary infections is quite often described. 42 Catheter-associated urinary tract infection is the most common nosocomial infection, accounting for more than one million cases every year in American hospitals and NHs. 43 A large-scale epidemiological study in The Netherlands has shown that orofacial pain has an increasing incidence rate with age for most of the pain diagnoses in the general population, with rates as high as 30.6 for trigeminal neuralgia and 44.2 for post-herpetic neuralgia. 44 In nursing homes in Austria, it was found that 28.9% of the institutionalized elderly experienced acute dental pain during the preceding year, and that almost half of these individuals required dental treatment for their pain complaints. 45 Our own data from 18 nursing homes in Norway suggest that 23% of the individuals are judged to be in orofacial pain (unpublished data). A summary view of the epidemiology of pain in older people living in nursing homes would be that diseases related to head, abdominal, chest, pelvis and skin are frequent (about 40% of those who are in pain), but that pain complaints are less improved by treatment, especially in visceral pain, and orofacial pain.
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ASSESSMENT OF PAIN IN PEOPLE WITH
DEMENTIA
Proper assessment of pain is a prerequisite for successful pain treatment and depends on the patients' memory, expectation, and self-report capacity. 46, 47 Therefore, when older adults in pain also have severe cognitive impairments, lack of language and abstract thinking they are at high risk for being under-diagnosed and under-treated.
In response to a strong need to assess pain and improve the treatment, behavioural pain assessment tools have been developed and tested, and reviewed in the literature. 19, 20, [48] [49] [50] [51] [52] [53] Instruments are based on observation of the patients' typical behaviour that might be related to pain, such as vocalization (e.g. moaning), facial expression (e.g. grimacing), and body movements (e.g. defense). There is also strong evidence that some behaviours like agitation, pacing or resisting care are related to present pain problems. However, such predictors will always be difficult to interpret, because symptoms attributed to neuropsychiatric disturbances (such as behaviour in dementia, delirium, depression and anxiety) may overlap indicators of pain.
Under-diagnosis of pain and potential side effects of medication are therefore a particular risk in older adults with dementia, especially for those in the advanced stages of dementia. 50, 51 In recognition of these complicating factors, a panel on Persistent Pain in Older Persons, convened by the American Geriatric Society 41, 52, 53 has recommended a comprehensive disease-specific, individual assessment of the patients' typical pain behaviour using a validated pain assessment tool as a prerequisite for appropriate pain treatment. However, recommendations of the AGS Panel are based on experiences in older adults without dementia. This is of key importance, because in dementia symptoms attributed to neuropsychiatric disturbances may overlap with indicators of pain and thus, make interpretation challenging. 48 In the last 35 years, more than 35 pain assessment instruments for older persons with dementia have been developed, tested, and reviewed in the literature. 19, 20, [48] [49] [50] [51] [53] [54] [55] Most of these instruments are based on the idea that the patients' acute or chronic pain experience is communicated by changes in facial expression, vocalization, and body movements. 22 It has also been suggested that one of the primary functions of pain behaviour is to elicit the aid of others. 56 One of the first instruments developed that tries to assess non-verbal behavior is the Facial Action Coding System (FACS). 56 The FACS is based on anatomical analysis of visible facial movements which are categorized as Action Units. Using the FACS, it has been shown that there is a small subset of facial actions that occur in the context of pain (e.g. narrowing the eye aperture). Since the development of the FACS in 1978, clinicians and international research groups have worked continuously and engaged with this important topic. Currently there are different types of pain assessment tools available dependent on self-report or proxy-rating by a caregiver who observe and interpret the typical pain behaviour of the patient.
SELF-REPORT ASSESSMENT
Self-report is the most appropriate method for pain assessment in the early stages of dementia, when pain can still be recognized and verbalized. 55 However, a study which aimed to assess the performance of selfassessment scales (the verbal, horizontal visual, and faces pain scales) found that only 61% of 129 severely demented patients demonstrated comprehension of at least one scale. Comprehension was defined as the ability to explain the scale use and correctly indicate positions for no pain and extreme pain on two separate occasions. Although others have described self-report approaches to be less reliable and applicable in the advanced stages of dementia, future research is needed to include and test the patients' self-report abilities, and clinicians and researchers should be careful to use a scale that suits the individual.
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CAREGIVERS PAIN BEHAVIOUR RATING SCALES
Most of the observational caregiver pain behaviour rating scales are developed after literature review and interviews with nursing staff, and include observational items related to facial expressions, vocalization, and body movements. [57] [58] [59] Most of these items are assessed by frequency, intensity, presence or absence of pain behaviour by the rater. Usually, staff evaluations are conducted at rest after some minutes of observation, but sometimes the patients are observed during daily life activities. Although the included items are based on recommendations by the AGS Panel, the interpretation of the total pain intensity, the scoring method, and instructions for staff training are often not clearly established. In addition, different scoring systems of presumed intensity of pain make the use of the tools challenging and suitable for research purposes only.
Based on relevant review articles the following observational assessment tools seem to be the most promising to assess pain in patients with dementia:
• Pain Assessment for the Dementing Elderly (PADE) • Pain Assessment in Non-Communicative Elderly (PAINE) • The Abbey Pain Scale • The Discomfort Scale for Dementia of Alzheimer Type (DS-DAT) 60 • The Checklist of Nonverbal Pain Indicators (CNPI) 61, 62 • The Pain Assessment in Advanced Dementia (PAINAD) 63 • The DOLOPLUS 2 64, 65 • The Pain Assessment Checklist for Seniors with limited Ability To Communicate (PACSLAC) [66] [67] [68] • The Assessment of Discomfort in Dementia (ADD) Protocol
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• The Non-Communicative Patient' s Pain Assessment Instrument (NOPPAIN) 69 • The Elderly Caring Assessment 2 (EPCA-2) 70 • The Mobilization-Observation-BehaviourIntensity-Dementia (MOBID-2) Pain Scale 36, [71] [72] [73] It is realized that observation of the patient at rest may not disclose the pain, especially in chronic pain, and suggestions are made that movement-related pain are better disclosed during ADL functioning. Thereby, at least four of these scales include spontaneous or guided movements during the pain observation process. 64, 69, 73, 74 Most of these scales are easy to use, but require training and time for proper administration. In the last years, doctors, nurses, and other caregivers have been involved in the validation processes. Although results are promising related to aspects of validity and reliability for several assessment tools, future studies are needed to define the most appropriate pain behaviour items which are able to discriminate between pain behaviour and behaviours related to other aspects of unmet needs.
In the Netherlands, the recently developed guideline "chronic pain in vulnerable elderly" identified several instruments that are available in Dutch. Based on psychometric properties and feasibility, three are recommended: PACSLAC-D (a shortened version of the PACSLAC), PAINAD and Doloplus.
In Norway, a recently developed observational tool, the MOBID-2 Pain Scale is used in nursing home settings. Assessment of pain intensity is based on the patient's immediate pain behaviour (vocalization, facial expression, and body movements) in connection with standardized, guided movements of different body parts, and pain behaviour related to internal organs. 73 MOBID-2 part 1 assesses pain related to the musculoskeletal system, and MOBID-2 part 2 assesses pain that might originate from internal organs, head and skin, being monitored over time. Primary caregivers are encouraged to judge whether the behavioral disturbances are related to pain or to dementia and psychogeriatric conditions. The total MOBID-2 score (0-10) is derived from caregivers in a clinical bedside situation during morning care. Psychometric property studies have indicated high to excellent reliability and validity, [71] [72] [73] and the assessment tool has been found feasible to use in clinical practice. 36, 75 Administration of the MOBID-2 takes approximately 5 minutes.
Including 77 nursing home residents with severe dementia, assessed by the Mini Mental State Examination (MMSE score 2.4 ± 3.6), we found that nociceptive pain (MOBID-2 Pain Scale ≥ 3) related to the musculoskeletal system was observed in 58% of the patients. 73 Most frequently painful was mobilizing the legs, and least was mobilizing the hands. The prevalence of pain originating from internal organs, head, and skin was slightly less frequent, as about 42% of the patients were estimated to be in pain due to these conditions. Most frequently observed and painful was pain that might originate from pelvis and/genital organs, and least was pain localized to the heart region, lung, and chest wall. Regarding the overall pain intensity, the prevalence of pain was suggested to be as high as 64% in nursing home patients with severe dementia.
LIMITATIONS OF EXISTING INSTRUMENTS
Taking together, a valid outcome measure of pain is the prerequisites for trials of pain treatment and assessment of potential analgesic side effects. In the last years, the development of single instruments is derivative of other instruments, including different aspects of pain behaviour and pain intensity, location and duration of pain, pain observed at rest or during movements, and self-report if still possible. Evaluations of the most promising observational pain assessments with nonverbal older adults with dementia indicated that although a number of tools demonstrate some potential, none of them has been shown to have sufficient practical utility as a tool that inform the physician as to when pain treatment will be beneficial. 59 A further limitation is that some instruments are not validated in an English-speaking population. 64, 70, 73 In addition, hardly any information is available on how to assess orofacial and/or dental pain. 49 This is of key importance, because impaired chewing, infections, and pain in the mouth may result in chronic malnutrition, poorer physical activity and more suffering.
Another concern is related to the scoring system. Most instruments add up the number of observed behaviours to present a total score. This means that a high number of behaviours indicate more pain. How-ever, a patient may be in severe pain although it is manifested only in a few items, for instance in connection with moving a leg or an arm, and the rest of the body is pain free. Some patients with for instance Parkinson disease or a severely reduced condition would not be able to express enough behaviour to be judged to be in pain. 73 Others, such as patients with Huntington's chorea, may express too much, even when there is no pain. Although pharmacological treatment with analgesics is the most common form of pain treatment in older persons, the use of non-pharmacological and alternative treatment should also be considered, especially under the aspect of potentially less adverse events.
TREATMENT RECOMMENDATIONS
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PREVALENCE STUDIES OF ANALGESIC DRUG
USE IN DEMENTIA
Traditionally, medications with analgesic effects are classified into three groups: periphery analgesics, such as acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), and opioid agents. Adjuvant medication (such as antidepressants, antiepileptic, hypnotics, anxiolytics, antipsychotics, and steroids) supports analgesic effects, but research results are only available for patients without mental impairment. Even when pain is assessed and recognized, pain management often falls short of prescription recommendations. This seems to be a worldwide challenge, documented by studies from The Netherlands, 83, 84 Belgium, 85 England, 86 Norway, 36, 87 Sweden, 88 United States 78,89-91 or China. 92 A study of 21,380 people living in nursing homes in 13 US states identified persistent pain in 49% of those studied. 91 Yet, 24% of those with persistent pain received no analgesics, and less than half of the medications were prescribed as standing orders. Acetaminophen was the most frequently prescribed analgesic and often at doses <1300 mg/day.
A study on the knowledge and beliefs of nurses caring for older adults with dementia in a nursing home setting found that a large number of the professionals thought patients should only receive analgesics "when necessary" rather than on a fixed schedule. 93 However, deficits or misbelieves about the care of older adults can affect all clinicians, not just nurses. Better cognition has been associated with a greater likelihood of receiving an analgesic other than acetaminophen. In a study of 551 nursing home residents in North Carolina, 56% of the individuals with severe cognitive impairment received pain medications, compared with 80% of the cognitively intact cohort (P < .001) despite a similar rate of pain-related conditions between the groups. 94 Notably, cognitively impaired persons were more likely to be given "as needed" pain medications while their peers had regularly scheduled analgesics. "As needed" drug regimens are particularly inappropriate for individuals with moderate-to-severe cognitive impairment who are unable to verbally communicate the presence of pain, much less a need for analgesics. 27, 78, 91, 95 But time is changing. Recently, increasing awareness of pain management in patients with dementia has been reported in the Swedish National Study of Aging and Care -Kungsholmen. 96 The study analyzed use of analgesics and psychotropics in 2610 participants aged > 65 years and found that 46% of the patients with dementia used at least one analgesic drug compared with 25% of those without dementia. Persons with dementia reported pain less frequently, but the prevalence of pain-related diagnoses was similar compared to persons without dementia. In this study, persons with dementia had higher probability of use of paracetamol (acetaminophen) and psychotropics, whereas there were no significant differences in use of any analgesic, opioids, and NSAIDs compared to those without mental impairment.
These results are supported by another study which compared the use of central nervous system drugs and analgesics among 546 people aged 85 years and older, with and without dementia living at home or institutions in Sweden and Finland. 97 A significantly higher proportion of patients with dementia used paracetamol, antipsychotics, antidepressant and anxiolytics. No differences were found for opioids. The first national population study in Finland to investigate opioid analgesic use among persons with and without dementia found that the use of strong opioids, especially due to transdermal fentanyl, was higher in patients with dementia. In Finland, sales of transdermal fentanyl increased by 98% between 2002 and 2006. 98 Finally, increasing warnings have been made against morbidity and death associated events with the initiation of fentanyl in previously opioid-naïve patients 99 and the urgent request to find the balancing act between appropriate pain treatment and unbearable side effects. 100 At the moment, we do not have comparable tends in order to the prescription of analgesic use in Norway. It will be a future task to describe available cohort data from the last years and actual nursing home trajectory studies.
CONCLUSION
Advanced age is associated with increased prevalence of pain and of dementia. Given that the ability to report about pain depends on the patient's memory, expectation, and emotion. Therefore, these patients are at high risk for being underdiagnosed and untreated for pain which may contribute to increasing behavioural disturbances like agitation, aggression: at any given time 45-89% suffer from pain and up to 80% have challenging behaviour. International recommendations to assess and treat pain have been published and an impressive number of pain behaviour rating scales have been developed and tested. However, implementation of these efforts seems to be a major shortcoming: Although, the total number of prescribed analgesics seems to increase in nursing homes, it is not guaranteed that the "right patient receives the right medication". It is, moreover, an alarming fact that these patients are still excluded from high quality RCT trials of pain treatment in dementia. This underlines high needs of research as well as excellent implementation concepts in the nursing home.
